Please try another search
Nichi-Iko Pharmaceutical Co., Ltd. manufactures, sells, and distributes various pharmaceutical products. It operates through two segments, Nichi-Iko Group and Sagent Group. The company primarily focuses on the production of generic drugs. It offers antidiabetic agents, antacids, antireflux agents, beta-blocker, hypnotic and sedative, angiotensin ? antagonist, angiotensin ? antagonist/diuretic combination, dyslipidaemic agent, and calcium antagonist products, as well as chemotherapeutic agents. The company also provides treatments for circulatory, digestive, respiratory, nervous system, allergies, and others. It supplies its products to medical institutions, including hospitals, clinics, dispensing pharmacies, etc. The company was formerly known as Nihon Iyakuhin Kogyo Co., Ltd. and changed its name to Nichi-Iko Pharmaceutical Co., Ltd. in 2005. Nichi-Iko Pharmaceutical Co., Ltd. was incorporated in 1947 and is headquartered in Toyama, Japan.
Name | Age | Since | Title |
---|---|---|---|
Shigetoshi Ebihara | - | 2023 | Independent Outside Director |
Makoto Shirakami | - | 2023 | Independent Outside Director |
Takashi Niina | - | 2023 | Independent Outside Director |
Osamu Mihara | 52 | 2022 | Director & Senior Managing Executive Officer |
Keisuke Enomoto | - | 2023 | Independent Outside Director |
Yoshihito Ofuji | - | 2023 | Independent Outside Director |
Shingo Iwamoto | - | 2023 | Representative Director & President |
Takashi Kashiwagi | - | 2024 | Senior Exe. Off., Head of Corporate Strategy & Planning Divi. and Outside Director |
Susumu Kanda | 62 | 2022 | Managing Executive Officer & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review